Literature DB >> 32037922

How to manage iron toxicity in post-allogeneic hematopoietic stem cell transplantation?

George J Kontoghiorghes1.   

Abstract

Entities:  

Keywords:  Iron overload; deferasirox; deferiprone; deferoxamine; hematopoietic stem cell transplantation; iron toxicity; leukemia; myelodysplasia; phlebotomy; thalassemia

Mesh：

Substances：

Year:  2020        PMID： 32037922     DOI： 10.1080/17474086.2020.1719359

Source DB:  PubMed          Journal:  Expert Rev Hematol        ISSN： 1747-4094            Impact factor:   2.929


× No keyword cloud information.
  9 in total

1.  Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin level.

Authors:  Warren Fingrut; Arjun Law; Wilson Lam; Fotios V Michelis; Auro Viswabandya; Jeffrey H Lipton; Rajat Kumar; Jonas Mattsson; Dennis Dong Hwan Kim
Journal:  Ann Hematol       Date:  2021-01-07       Impact factor: 3.673

2.  How I transplant a patient with a history of invasive fungal disease.

Authors:  Pedro Puerta-Alcalde; Richard Champlin; Dimitrios P Kontoyiannis
Journal:  Blood       Date:  2020-08-26       Impact factor: 22.113

3.  How I perform hematopoietic stem cell transplantation on patients with a history of invasive fungal disease.

Authors:  Pedro Puerta-Alcalde; Richard E Champlin; Dimitrios P Kontoyiannis
Journal:  Blood       Date:  2020-12-10       Impact factor: 22.113

Review 4.  Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology.

Authors:  George J Kontoghiorghes
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

Review 5.  The Role of Iron in Benign and Malignant Hematopoiesis.

Authors:  Sayantani Sinha; Joana Pereira-Reis; Amaliris Guerra; Stefano Rivella; Delfim Duarte
Journal:  Antioxid Redox Signal       Date:  2021-01-07       Impact factor: 7.468

6.  Questioning Established Theories and Treatment Methods Related to Iron and Other Metal Metabolic Changes, Affecting All Major Diseases and Billions of Patients.

Authors:  George J Kontoghiorghes
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

7.  Deferoxamine Inhibits Acute Lymphoblastic Leukemia Progression through Repression of ROS/HIF-1α, Wnt/β-Catenin, and p38MAPK/ERK Pathways.

Authors:  Hongliang You; Dao Wang; Linlin Wei; Jiao Chen; Huanhuan Li; Yufeng Liu
Journal:  J Oncol       Date:  2022-02-21       Impact factor: 4.375

Review 8.  Mechanistic Insights of Chelator Complexes with Essential Transition Metals: Antioxidant/Pro-Oxidant Activity and Applications in Medicine.

Authors:  Viktor A Timoshnikov; Olga Yu Selyutina; Nikolay E Polyakov; Victoria Didichenko; George J Kontoghiorghes
Journal:  Int J Mol Sci       Date:  2022-01-23       Impact factor: 5.923

Review 9.  Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases.

Authors:  George J Kontoghiorghes; Christina N Kontoghiorghe
Journal:  Cells       Date:  2020-06-12       Impact factor: 6.600
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.